UK launches large-scale study on impact of cancer care via molecular tumor boards
Jill Kolesar, Pharm.D., a professor in UK’s College of Pharmacy and co-director of the UK Markey Cancer Center Molecular Tumor Board, is principal investigator of a study examining the impact molecular tumor board review has in cancer patient outcomes. She talks about it this week on Dr. Greg Davis on Medicine.
UK launches large-scale study on impact of cancer care via molecular tumor boards
Jill Kolesar, Pharm.D., a professor in UK’s College of Pharmacy and co-director of the UK Markey Cancer Center Molecular Tumor Board, is principal investigator of a study examining the impact molecular tumor board review has in cancer patient outcomes. She talks about it this week on Dr. Greg Davis on Medicine.